Abstract PS3-07-26: Precision neoadjuvant treatment with Artificial Intelligence assisted subtyping in HR+/HER2- breast cancer: a randomized, open-label, phase 2 trial FASCINATE-N
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institution: Fudan University Shanghai Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130686224
Cites:
Cited by:
Related to:
